Skip to search formSkip to main contentSkip to account menu

ELF Regimen

A regimen consisting of etoposide, leucovorin and fluorouracil used for the treatment of advanced-stage gastric cancer.
National Institutes of Health

Related topics

Related topics

4 relations
EtoposideFluorouracilLeucovorin CalciumStomach Carcinoma

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
The clinical evaluation of ELF regimen combined with oxaliplatin in the treatment of advanced gastric cancer
Objective To evaluate the efficacy of the combination of ELF( VP16/CF/5-Fu) and oxaliplatin in the treatment of advanced gastric… 
2011
2011
Evaluation of ELF regimen combined with oxaliplatin in treatment of advanced carcinoma of stomach
The objective of this study was to observe the therapeutic effect and safety of ELF combined with oxaliplatin in treatment of… 
2009
2009
[Oxaliplatin combined with ELF regimen in the treatment of patients with advanced gastric cancer].
OBJECTIVE To evaluate the efficacy and safety of the combination of oxaliplatin and ELF (VP16/CF/5-Fu) regimen in the treatment… 
2009
2009
Weekly docetaxel, cisplatin and low dose fluorouracil for advanced gastric carcinoma: a randomized clinical trial
ObjectiveThe aim of this study was to investigate the efficacy of weekly docetaxel (TXT), cisplatin (DDP) combined with… 
2007
2007
Clinical observation on the effect of ELF regimen combined with intra-arterial infusion of carboplatin on advanced gastric carcinoma
Objective:To compare the effects of ELF regimen combined with intra-arterial or intravenous infusion of carboplatin on advanced… 
2004
2004
A phase II study of oxaliplatin with ELF regimen in patients with advanced gastric cancer.
4206 Background: ELF (Etoposide, Leucovorin, 5-FU) regimen is widely used in gastric cancer. Oxaliplatin (Eloxatin) is a third… 
2003
2003
Clinical Study of ELF Regimen in the Treatment of Advanced Gastric Cancer
2002
2002
Treatment of advanced gastric cancer with etoposide, folinic acid, and fluorouracil in the clinical setting
The combination of etoposide, folinic acid, and 5-fluorouracil (5-FU) (ELF regimen) has been proved to be an active chemotherapy… 
2000
2000
[Preliminary clinical comparison of HLF and ELF regimen in the treatment of advanced gastric carcinoma in middle-aged and elderly patients].
OBJECTIVE To observe the therapeutic effects and toxicity of HLF (hydroxycamptothecin HCPT/leucovorin LV/fluorouracil 5-Fu… 
1994
1994
Elf regimen in advanced gastrointestinal malignancies - an analysis of its clinical effectiveness and toxicity.
A multi-institutional phase 11 study of the combination of levofolinic acid 100 mg/m2, VP16 120 mg/m2 and 5-fluorouracil 500 mg… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)